Cargando…
Explaining the Release Mechanism of Ritonavir/PVPVA Amorphous Solid Dispersions
In amorphous solid dispersions (ASDs), an active pharmaceutical ingredient (API) is dissolved on a molecular level in a polymeric matrix. The API is expected to be released from the ASD upon dissolution in aqueous media. However, a series of earlier works observed a drastic collapse of the API relea...
Autores principales: | Krummnow, Adrian, Danzer, Andreas, Voges, Kristin, Dohrn, Stefanie, Kyeremateng, Samuel O., Degenhardt, Matthias, Sadowski, Gabriele |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9505701/ https://www.ncbi.nlm.nih.gov/pubmed/36145652 http://dx.doi.org/10.3390/pharmaceutics14091904 |
Ejemplares similares
-
Kinetics of Water-Induced Amorphous Phase Separation in Amorphous Solid Dispersions via Raman Mapping
por: Krummnow, Adrian, et al.
Publicado: (2023) -
Predicting process design spaces for spray drying amorphous solid dispersions
por: Dohrn, Stefanie, et al.
Publicado: (2021) -
Thermodynamic Modeling of the Amorphous Solid Dispersion-Water Interfacial Layer and Its Impact on the Release Mechanism
por: Dohrn, Stefanie, et al.
Publicado: (2023) -
A Hot-Melt Extrusion Risk Assessment Classification System for Amorphous Solid Dispersion Formulation Development
por: Kyeremateng, Samuel O., et al.
Publicado: (2022) -
Amorphous solid dispersion formation via solvent granulation – A case study with ritonavir and lopinavir
por: Trasi, Niraj S., et al.
Publicado: (2019)